
Shares in Prothena have dropped by close to 70% on the news that two of its trials into its lead …

Somewhat unusually for an early drug development deal, Biogen has put down a serious amount of cash up-front in its …

After a parliamentary debate in the House of Commons regarding making Orkambi available to patients with cystic fibrosis (CF), MPs …

It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …

After the FDA advisory committee unanimously recommended GW Pharma’s Epidiolex for approval, the chances of it not receiving the nod …

Allergan performed an odd about-turn after initially declaring its interest in pursuing a deal for Shire, before reneging on that …

BenevolentAI, a London based drug discovery biotech, has revealed that a $115 million financing round now sees the company valued …

Merck KGaA has successfully found a buyer for its healthcare unit, after Proctor & Gamble announced that it was prepared …

The first stage of separation for the EMA from the UK came with the decision to relocate its headquarters to …

Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK …

After a busy start to the year, with a number of acquisitions and a few divestments, Sanofi’s Chief Financial Officer, …

GW Pharma are inching step by step towards a likely approval with the FDA, after it received a strong recommendation …

Two weeks ago, it looked like the hopes for Alkermes’ ALKS 5461 receiving approval would rely on returning to the …

Last year buzz about Amazon entering the pharmaceutical distribution market steadily grew after it obtained pharmacy licenses in a small …

Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …